Introduction: This chapter describes the characteristics of adult patients starting renal replacement therapy (RRT) in the UK in 2009 and the acceptance rates for RRT in Primary Care Trusts and Health Boards (PCT/HBs) in the UK. Methods: The basic demographics and clinical characteristics are reported on patients starting RRT from all UK renal centres. Late presentation, defined as time between first being seen by a nephrologist and start of RRT being <90 days was also studied. Age and gender standardised ratios for acceptance rates in PCT/HBs were calculated. Results: In 2009, the incidence rate in the UK and England was 109 per million population (pmp). Acceptance rates in Scotland (104 pmp), Northern Ireland (88 pmp) and Wales (120 pmp) had all fallen although Wales still remained the country with the highest acceptance rate. There were wide variations between PCT/HBs with respect to the standardised ratios. The median age of all incident patients was 64.8 years (IQR 50.8, 75.1). For transplant centres this was 63.0 years (IQR 49.0, 74.2) and for non-transplanting centres 66.3 years (IQR 52.6, 75.9). The median age for non-Whites was 57.1 years. Diabetic renal disease remained the single most common cause of renal failure (25%). By 90 days, 69.1% of patients were on haemodialysis, 17.7% on peritoneal dialysis, 6.7% had had a transplant and 6.5% had died or stopped treatment. The mean eGFR at the start of RRT was 8.6 ml/min/1.73 m 2 which was similar to the previous two years. Late presentation (<90 days) 
(120 pmp) had all fallen although Wales still remained the country with the highest acceptance rate. There were wide variations between PCT/HBs with respect to the standardised ratios. The median age of all incident patients was 64.8 years (IQR 50.8, 75.1). For transplant centres this was 63.0 years (IQR 49.0, 74.2) and for non-transplanting centres 66.3 years (IQR 52.6, 75.9). The median age for non-Whites was 57.1 years. Diabetic renal disease remained the single most common cause of renal failure (25%). By 90 days, 69.1% of patients were on haemodialysis, 17.7% on peritoneal dialysis, 6.7% had had a transplant and 6.5% had died or stopped treatment. The mean eGFR at the start of RRT was 8.6 ml/min/1.73 m 2 which was similar to the previous two years. Late presentation (<90 days) has fallen from 27% in 2004 to 19% in 2009. There was no relationship between social deprivation and presentation pattern. Conclusions: Acceptance rates have fallen in Northern Ireland, Scotland and Wales whilst they have plateaued in England over the last four years. Wales continued to have the highest acceptance rate of the countries making up the UK.
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Introduction
This chapter includes analyses of adult patients starting renal replacement therapy (RRT) in the UK in 2009. It describes regional and national variations in acceptance rates onto RRT in the UK, the demographics and clinical characteristics of all patients starting RRT in the UK and late presentation to a renal centre for initiation of RRT. The methodology and the results for these analyses are discussed in three separate sections.
Definitions
The definition of incident patients is given in detail in appendix B: definitions and analysis criteria (www. renalreg.com/Report-Area/Report2010/appendix-B.pdf). In brief, it is all patients over 18 who commenced RRT in the UK in 2009 and who did not recover renal function within 90 days: this does not include those with a failed renal transplant who return to dialysis as they started RRT with or before the transplant.
Small differences may be seen in the 2004 to 2008 figures now quoted when compared with previous publications because of retrospective updating of data in collaboration with renal centres, in particular for patients who were initially thought to have acute renal failure. As last year, rather than allocating all preemptive transplants to the transplanting centre, an attempt was made to allocate these patients to their work up centre. This was not possible for all such patients and consequently some patients probably remained incorrectly allocated to the transplanting centre.
The term established renal failure (ERF) used within this chapter is synonymous with the terms end stage renal failure (ESRF) and end stage renal disease (ESRD), which are in more widespread international usage. Within the UK, patient groups have disliked the term 'end stage' which formerly reflected the inevitable outcome of this disease.
UK Renal Registry coverage
The UK Renal Registry (UKRR) received individual patient level data from all adult renal centres in the UK (5 renal centres in Wales, 6 in Northern Ireland, 9 in Scotland and 52 in England). Data from centres in Scotland were obtained from the Scottish Renal Registry. Data on children and young adults can be found in chapter 5: Demography of the UK Paediatric Renal Replacement Therapy population in 2009.
Geographical variation in acceptance rates
Over the years, there have been wide variations in acceptance trends between renal centres. Equity of access to RRT is an important aim but the need for RRT depends on many variables including age, gender, social deprivation, ethnicity and medical, social and demographic factors such as underlying conditions. Thus comparison of crude acceptance rates by geographical area can be misleading. This year's report again uses age and gender standardisation as well as showing crude rates. It also gives the ethnic minority percentage of each area as this influences acceptance rates. More detailed investigations into variation in acceptance rates are continuing at the UKRR.
Methods
Crude acceptance rates were calculated per million population (pmp) and standardised acceptance ratios were calculated as detailed in appendix D: methodology used for analyses of PCT/ HBs (www.renalreg.com/Report-Area/Report2010/appendix-D.pdf). Briefly, data from all areas covered by the Registry for the relevant year were used to calculate overall age and gender specific acceptance rates. The age and gender breakdown of the population in each Primary Care Trust (PCT) area in England, Local Health Board (HB) in Wales, Scottish Health Board (HB) and the Health and Social Care Trust Areas in Northern Ireland (HSC) was obtained from the Office for National Statistics (ONS) [1] . These will be referred to by the umbrella term 'PCT/HB' in this report. This population breakdown was extrapolated by the ONS from the 2001 census data to mid-2009 estimates. For Wales and Northern Ireland the population data were aggregated from local authority to health board level. The population breakdown and the overall acceptance rates were used to calculate the expected age and gender specific acceptance numbers for each PCT/HB. The age and gender standardised acceptance ratio was the observed acceptance numbers divided by the expected acceptance numbers. A ratio below 1 indicated that the observed rate was less than expected given the area's age structure. This was statistically significant if the upper confidence limit was less than 1. Analyses were undertaken for each of the last 6 years and, as the incident numbers for one year can be small for smaller areas, a combined 6 years analysis was also done. The proportion of non-Whites in each PCT/HB area was obtained from the ONS from the 2001 Census for Northern Ireland, Scotland and Wales and from the ONS revised estimates for 2007 for England.
As part of continuing quality control, checks on the accuracy of data received are repeatedly carried out. A small degree of underreporting of patients has been identified for 2009 in the following centres: Belfast (9), Dorset (9), Basildon (3), Antrim (3), Derry (3), Norwich (3), Doncaster (1), Tyrone (1), Ulster (1), Newry (1), Chelmsford (1), total 35. These patients have been added to tables 1.1 and 1.3 and figure 1.1 but are not included in any other analyses in this chapter. 
Results
In 2009 the number of adult patients starting RRT in the UK was 6,730 equating to an acceptance rate of 109 pmp (table 1.1), slightly higher than in 2008. Wales remained the country with the highest acceptance rate (figure 1.1). For England, acceptance rates have been stable for the last 4 years. There continued to be very marked gender differences in take-on rates, 137 pmp (95% CI 133-141) in males and 82 pmp (95% CI 78-85) in females. Table 1 .2 shows acceptance rates and standardised ratios for PCT/HBs. The ratios calculated using combined data from up to six years have been used in determining significantly high and low areas. Provided that the area has been covered by the Registry for at least three years (all but one PCT/HB) significantly high areas have been shaded with bold text and significantly low areas shaded with italicised text in table 1.2. There were wide variations between areas, with 49 being significantly high and 47 being significantly low out of a total of 178 areas. As would be expected, urban areas with high percentages of non-White residents tended to have high acceptance rates. Figure 1 .2 shows the positive correlation between the standardised ratios and the percentage of the PCT/HB that is non-White.
Confidence intervals are not presented for the crude rates per million population but figures D1 and D2 in appendix D (www.renalreg.com/Report-Area/Report2010/appendix-D.pdf) show the confidence limits around the national average rate for different sized areas and allow an individual area's rate to be compared to the average to ascertain if it is higher or lower than expected.
The number of new patients accepted by each renal centre from 2004 to 2009 is shown in table 1.3, along with the percentage change in incident number between these years for those centres with full reporting during that period. Some centres have had an increase in new patients over time and others have fallen. The variation may reflect chance fluctuation, the introduction of new centres, completeness of reporting, changing incidence of established renal failure, changes in referral patterns, changes in catchment populations and areas or the introduction of conservative care programmes. For the first time this year the rate per million population has been presented for each centre. This has previously not been possible as accurate catchment populations were not available. For a full description of the methodology used see appendix E: methodology for estimating catchment populations (www.renalreg.com/Report-Area/ Report2010/appendix-E.pdf). In brief, the patient postcode for each prevalent dialysis patient in 2007 was used to create a series of overlapping areas corresponding to each renal centre. These small areas were then assigned to a Census Area Statistics ward using geographical information system technology and the population in each area assigned to its respective renal centre. 50   60   70   80   90   100   110   120   130   140   150   1990  1991  1992  1993  1994  1995  1996  1997  1998  1999  2000  2001  2002  2003  2004  2005  2006  2007  2008 Gilg/Castledine/Fogarty/Feest Gilg/Castledine/Fogarty/Feest Gilg/Castledine/Fogarty/Feest 
Methods
Age, gender, primary renal disease, ethnic origin and modality were examined for patients starting RRT.
Some centres electronically upload ethnicity coding to their renal information technology (IT) system from the hospital Patient Administration Systems (PAS). Ethnicity coding in these PAS systems is based on self-reported ethnicity and uses a different coding system [2] . For the remaining centres, ethnicity coding is performed by clinical staff and recorded directly into the renal IT system (using a variety of coding systems). For all these analyses, data on ethnic origin were grouped into Whites, South Asians, Blacks, Chinese and Others. The details of regrouping of the PAS codes into the above ethnic categories are provided in appendix H: ethnicity and ERA-EDTA coding (www.renalreg.com/ReportArea/Report2010/appendix-H.pdf). Chi-squared, Fisher's exact, ANOVA and Kruskal Wallis tests were used as appropriate to test for significant differences between groups.
Estimated glomerular filtration rate (eGFR) at the start of RRT was studied amongst patients with eGFR data within 14 days before the start of RRT. The eGFR was calculated using the abbreviated 4 variable MDRD study equation [3] . For the purpose of the eGFR calculation, patients who had missing ethnicity but a valid serum creatinine measurement were classed as Whites. The eGFR values were log transformed in order to normalise the data. Patients with an eGFR >20ml/min/1.73 m 2 were excluded from the eGFR analyses due to concerns about possible data extraction errors.
Results

Age
Incidence rates within the UK have levelled off in the last three years. (figure 1.3) . Figure 1 .4 shows RRT incidence rates for 2009 by age band. For men, the peak is in the 80-84 age band, for women 75-79, and overall 75-79 (the high male peak at 80-84 does not shift the overall figure as there are relatively few people in this age band).
In 2009, the median age of patients starting renal replacement therapy was 64.8 years (table 1.4) and this has changed little over the last six years (data not shown). The median age of patients starting in England was lower than that of the other three countries of the United Kingdom possibly reflecting the larger ethnic minority population in England. The median age of incident UK non-White patients was considerably lower at 57.1 years. This reflects the younger age distribution of ethnic minority populations in general compared with the White population (5.1% of ethnic minorities were over 65 years old compared to 16.9% of whites) [4] and the higher rates of diabetes in South Asian and Black populations. Figure 1 .5 shows that the 55-64 age band contained the most patients starting on peritoneal dialysis whereas the 65-74 age band contained the most patients starting on haemodialysis.
There were large differences between centres in the median age of incident patients (figure 1.6). In part this reflects differences in the age and ethnic structure of the catchment populations and chance fluctuations, particularly in small centres. The median age of patients treated at transplant centres was 63.0 years (IQR 49.0, 74.2) and at non-transplanting centres 66.3 years (IQR 52.6, 75.9) (p < 0.0001). Gender As in previous years, more men than women started RRT in all age groups and this became more prominent with older age (figures 1.4 and 1.7).
In the UK as a whole, 61.7% of the 2009 incident cohort were male.
Ethnicity
This year, 51 centres returned ethnicity data that were 50% or more complete (table 1.5). Only 27 of these centres provided ethnicity data for 90% or more of their incident patients. Ethnicity is not a mandatory data item for the Scottish Renal Registry and Scotland has not been included in the table. The low completeness for some centres means results should be interpreted with caution. There was great variation between centres with respect to the ethnic mix of incident patients ranging from 0% ethnic minorities in Dorset, Wirral, Carlisle, Southend, Tyrone, Ulster, Derry and Wrexham to over 50% in London Barts and London Royal Free. Primary renal diagnosis The distribution of primary renal disease (PRD) by centre is shown in table 1.6. Data for PRD were missing in 9.9% of patients and there remained a marked difference between centres in completeness of data returns. Thirty centres provided data on all incident patients, whilst seven centres had more than 25% data missing for PRD. For the centres with >25% missing data, the percentages in the other diagnostic categories have not been shown in table 1.6.
The Registry continues to be concerned about centres with apparently very high data completeness for PRD but also very high rates of 'uncertain' diagnoses (EDTA codes 00 and 10). It is accepted that there will inevitably be a number of patients with uncertain aetiology and that the proportion of these patients will vary between clinicians and centres as the definitions of renovascular disease, hypertensive nephropathy and chronic glomerulonephritis without tissue diagnosis remain relatively subjective. The situation has improved from last year when diagnosis data for five centres was not used. This year data was not used from two centres which had diagnosis 'unknown' for over 50% of their incident patients with non-missing data. As the numbers with the specific PRDs are likely to be falsely low in these centres, the breakdown into these categories has not been shown in table 1.6. These centres have also been excluded from the other analyses where PRD is used to stratify analyses. A third centre had just over 50% with diagnosis 'unknown' but as this was a smaller centre it was possible that this was a chance finding and that centre has been kept in the analyses.
For the non-excluded centres, the overall UK percentage with uncertain aetiology (20.7%) is the same as for 2008 incident patients and again, there is great variation between centres. Some of this variation is likely to reflect the lack of a clear definition of certain diagnostic categories e.g. hypertensive renal disease and renal vascular disease; some may result from differences between centres in attitudes to the degree of certainty required to record other diagnoses. There were no missing data for Northern Ireland and only 0.9% for Scotland, whilst England and Wales had 11.2% and 8.6% respectively. This was a change from last year when Scotland had 13.5% missing data and Wales had 1.5%. The overall percentage missing is down from 10.8 for 2008 incident patients to 9.9% for 2009.
The overall distribution of PRDs is shown in table 1.7. Diabetic nephropathy was the most common specific renal diagnosis in both the under and over 65 year age groups, accounting for 25% of all (non-missing) incident diagnoses. Biopsy proven glomerulonephritis and autosomal dominant polycystic kidney disease (ADPKD) made up higher proportions of the younger than the older incident cohorts (16% vs. 7% and 10% vs. 3% repectively), whilst renal vascular disease was much more common in older incident patients (10% vs. 2%). It was perhaps not surprising that uncertainty about the underlying diagnosis was also more common in the older cohort (27% vs. 15%). The proportion of each major diagnosis has changed little in the last few years.
For all primary renal diagnoses except ADPKD, the male to female ratio was 1.4 or greater. This gender difference may relate to factors such as hypertension, atheroma and renal vascular disease, which are more common in males and more common with increasing age. These factors may influence the rate of progression of renal failure. Table 1 .8 shows the incidence rates for each PRD per million population in the 2009 cohort by country. As there are some missing data, the rates for each diagnosis will be underestimates.
First established treatment modality
The first treatment recorded, irrespective of any later change, was haemodialysis (HD) in 76.3% of patients, peritoneal dialysis (PD) in 17.9% and pre-emptive transplant in 5.9%. The proportion with HD as the first treatment modality has remained relatively stable over the last few years, though it has increased considerably since the late 1990s (58% of incident patients in 1998). The frequency of PD usage has fallen whilst pre-emptive transplantation has risen. This may be as a consequence of national initiatives to encourage live donation and pre-emptive transplantation thus improving pre-emptive transplant rates in the same group of younger, less comorbid patients approaching ERF who traditionally started on PD. Many patients, especially those presenting late, undergo a brief period of HD before switches to other modalities are, or can be, considered. Hence, the established modality at 90 days is more representative of the elective first modality. By 90 days, 6.3% of the 2009 incident patients had died and a further 0.2% had stopped treatment, leaving 93.5% of the original cohort on RRT. Table 1 .9 shows the percentages on each treatment at 90 days both as percentages of all of those starting and then of those still on treatment at 90 days.
For this analysis, the incident cohort from 1/10/2008 to 31/09/2009 was used so that follow up to 90 days was available for all patients. Expressed as a percentage of the whole incident cohort, 69.1% were on HD at 90 days, 17.7% were on PD and 6.7% had received a transplant. Expressed as a percentage of those still receiving RRT at 90 days, 73.9% were on HD, 18.9% on PD and 7.2% had received a transplant. Figure 1 .8 shows these percentages with the HD patients further subdivided. Of those still on RRT at 90 days, only 0.7% were receiving home haemodialysis, with the vast majority of HD patients on centre-based treatment either in main hospital centres (47.4% of total) or satellite units (25.8%). Although Northern Ireland continued to have a lower percentage of all patients on PD at 90 days compared with other parts of the UK, the percentages in the 3 other countries have all continued to fall, most dramatically in Wales (24.6% in 2007 to 20.9% in 2008 to 15.9% in 2009) and Scotland (21.3% to 18.1% to 13.5%). This comes at a time when the Department of Health is trying to increase the proportion of patients on home therapies. Gilg/Castledine/Fogarty/Feest It is possible that this is in part due to fears about encapsulating peritoneal sclerosis and improvements in haemodialysis provision that is closer to patients' homes.
The percentage of incident patients who had died by 90 days varied considerably between centres (0% to 20%, table 1.9). The definition of whether patients have acute or chronic renal failure may be a factor in this apparent variation.
The proportion with a functioning transplant at 90 days in different centres varied between 0% and 21%. The mean percentage of the incident cohort with a functioning transplant by 90 days was significantly greater in transplanting compared to non-transplanting centres (9.3% vs. 4.2%: p < 0.0001). One possible reason could be that some patients transplanted pre-emptively were attributed to the incident cohort of the transplanting centre rather than that of the referring centre (as mentioned earlier). Further information and analyses in this area can be found in chapter 13: Centre Variation in Access to Renal Transplantation in the UK. Table 1 .10 shows the HD/PD split for those incident patients on dialysis at 90 days. It also gives this split by age group. The percentage on PD at 90 days was almost twice as high in patients aged <65 years than in older patients (26.9% vs. 14.2%). The median age on HD was 67.1 years compared with 58.7 years for PD and these medians have been stable for 5 years.
Renal function at the time of starting RRT Some caution should be applied to the analysis of eGFR at the start of RRT. A review of pre-RRT biochemistry in nine renal centres revealed that up to 18% Introduction Late presentation to a nephrologist has many definitions and a range of possible causes. There are many patients with chronic kidney disease who are regularly monitored in primary or secondary care, and whose referral to nephrological services is delayed (delayed or late referral). In contrast other patients present late to medical services. Chronic kidney disease may be asymptomatic until very advanced stages resulting in no contact with medical services or patients may present with a variety of rapidly progressive kidney diseases: these patients are the true 'late presenters'. The analyses presented here do not differentiate between these groups and include any patient first seen by renal services within 90 days of requiring RRT as 'late presentation'.
Methods
Data were included from all incident patients in the years 2004 to 2009. The date first seen in a renal centre and the date of starting RRT were used to define the late presenting cohort. Around 5% of data were excluded because of actual or potential inconsistencies, it is hoped to address this before next year's report. Only data from those centres with 75% or more completeness were used. Data were excluded for centres in the years where 10% or more of the patients were reported to have started RRT on the same date as the first presentation, as investigation has shown that this is due to misunderstanding on the part of the renal centres resulting in incorrect recording of data. After these exclusions, data on 11,206 patients were available for analysis. Presentation times of 90 days or more were defined as early presentation and times of less than 90 days were defined as late presentation. There has been a steady decline nationally in the proportion of patients presenting late to renal services, with some centres achieving <10% late presentation rates. This may have been as a consequence of the National CKD guidelines published by the Medical and GP Royal Colleges [7] , the Quality and Outcomes Framework (QOF) initiative (www.dh.gov.uk) raising awareness of CKD amongst non-nephrologists and the introduction of estimated GFR reporting.
Results
Time referred before dialysis initiation in the 2009 incident cohort
In 2009, 67.1% of incident patients presented over a year before they needed to start dialysis. There were 7.2% of patients presented within 6-12 months, 6.3% within 3-6 months and 19.4% within 3 months. Table  1 .13 shows this breakdown by year for those 11 centres supplying data for each of the last 6 years with >75% completeness (Basildon, Bradford, Dorset, Leeds, Middlesbrough, Nottingham, Oxford, Portsmouth, Sheffield, Stevenage and Wolverhampton). The proportion of patients presenting late in these centres has steadily fallen since 2005 (figure 1.11), and there has been an increase in those presenting 12 months or more before starting RRT.
Age and late presentation
In the 2004 to 2009 cohort, patients who presented late were significantly older than patients who presented earlier (>90 days before dialysis initiation) (median age 67.0 vs. 64.7 years: p < 0.0001). The median duration of pre-RRT care diminished progressively with increasing age beyond the 45-54 age group (figure 1.12).
Gender and late presentation
There was no significant difference in the proportion of males to females by time of presentation (male:female ratio 1.64 in early presentation, 1.71 in late presentation, p ¼ 0.37).
Ethnicity, social deprivation and late presentation This analysis of the 2004 to 2009 cohort was limited to patients from centres with >70% ethnicity and >75% presentation time data. Patients from the Chinese and Other ethnic minority groups were excluded due to the small numbers with presentation data. The percentage of non-Whites (South Asian and Black) presenting late (<90 days) was significantly lower than in Whites (18.9% vs. 23.2%: p ¼ 0.0018). The high incidence of diabetes in non-Whites (as discussed below, patients with diabetes tended to present earlier) and the older median age of incident Whites may explain this finding. There was no relationship between social deprivation and presentation pattern. Primary renal disease and late presentation In the 2004 to 2009 cohort, late presentation differed significantly between primary renal diagnoses (Chisquared test p < 0.0001) (table 1.14). Patients with a diagnosis of 'other identified category' , 'not available' and the aetiology uncertain/glomerulonephritis unproven groups had higher rates of late presentation. Those with diabetes and adult polycystic kidney disease had lower rates. Over these 6 years, there has been a significant downward trend in the proportion of diabetics presenting late (Maentel-Haenszel Chi-squared test p ¼ 0.0001). This likely reflects national initiatives to screen patients with diabetes for proteinuria and falling GFR.
Modality and late presentation
In the 2004 to 2009 cohort, late presentation was associated with initial modality. The percentage of patients whose first modality was PD was significantly less in the late presentation group compared to those presenting earlier (10.8% vs. 25.9%: p < 0.0001). By 90 days after dialysis initiation this difference was reduced, although still highly significant (15.7% vs. 26.9%: p < 0.0001).
Comorbidity and late presentation
In the 2004 to 2009 cohort, a slightly lower percentage of patients who presented late were assessed as having no comorbidity when compared with the group who presented earlier, this just reached statistical significance (39.8% vs. 42.9%: p ¼ 0.02). Peripheral vascular disease and ischaemic heart disease were significantly less common in the group presenting late. Malignancy was significantly more common in those presenting late, perhaps because of the potential for rapid decline in renal function in this setting. Liver disease and smoking were also more common in those presenting late although for these the differences were only of borderline statistical significance (table 1.15).
Haemoglobin and late presentation
In the 2004 to 2009 cohort, patients presenting late had a significantly lower haemoglobin concentration at dialysis initiation than patients presenting earlier (9.4 vs. 10.5 g/dl: p < 0.0001). This may reflect inadequate pre-dialysis care with limited anaemia management, but alternatively those presenting late may be more likely to have anaemia because of multisystem disease or inter-current illness.
eGFR at start of RRT and late presentation In the 2004 to 2009 cohort, eGFR at start of RRT was lower in patients presenting late (7.5 vs. 8.4 ml/min/ 1.73 m 2 : p < 0.0001).
Survival of incident patients
This analysis is to be found in chapter 7: Survival and Causes of Death of UK Adult Patients on Renal Replacement Therapy in 2009. Figure 1 .13 shows the crude RRT incidence rates for 2004 to 2008 combined for several countries with complete coverage of their populations. The UK incidence rate is similar to many other Northern European countries and Australasia, but remains lower than Belgium, Greece, US, Japan and Taiwan. These differences are likely to be due to the rate of advanced kidney disease in these populations as well as lower mortality from competing risks for RRT, such as cardiovascular disease in southern Europe and the Far East. The healthcare system in use in these countries may also influence RRT incidence.
International comparisons
Summary
RRT incidence rates have fallen in Northern Ireland, Scotland and Wales whilst they have risen slightly in England over the last 3 years. Wales continued to have the highest incidence rate. There remained large centre variations in incidence rates for RRT. Significant numbers of patients continued to present late to renal centres but there was a continuing decline in late presentation rate overall with the most marked difference for those with diabetes. 
